Product Information
DONEPEZIL HCL 5 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0440 per EA under NDC 31722073790. Its NADAC has been published 551 times since Mar 16, 2016.
FDA first approved this application on Jan 30, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722073790
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DONEPEZIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203034FDA Approved
1/30/2015
TE Code
AB
On Market Since
2/2/2015
Pharmacological Classes
Price Statistics
The NADAC for DONEPEZIL HCL 5 MG TABLET has been published 551 times since Mar 16, 2016, and over the history we have for it it has declined 35.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0440 per EA |
|---|---|
| All-time high | $0.0722 (Apr 13, 2016) |
| All-time low | $0.0334 (May 22, 2024) |
| 52-week high | $0.0446 |
| 52-week low | $0.0424 |
| Median price | $0.0505 |
| Average price | $0.0510 |
| Largest weekly change | +28.3% (Nov 22, 2023) |
| Weeks tracked | 551 |
| Tracking since | Mar 16, 2016 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Donepezil hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinesterase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DONEPEZIL HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DONEPEZIL HCL 5 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.0440 per EA (NDC 31722073790), effective Sep 30, 2026.
How has the price of DONEPEZIL HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for DONEPEZIL HCL 5 MG TABLET has declined 35.3%. It has been tracked across 551 weekly CMS publications since Mar 16, 2016.
What are the highest and lowest recorded NADAC prices for DONEPEZIL HCL 5 MG TABLET?
Since Mar 16, 2016, the NADAC for DONEPEZIL HCL 5 MG TABLET has ranged from a low of $0.0334 (May 22, 2024) to a high of $0.0722 (Apr 13, 2016), with a median of $0.0505 per EA.
Are there cheaper alternatives to DONEPEZIL HCL 5 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DONEPEZIL HCL 5 MG TABLET, is $0.0438 per EA — about 0% below DONEPEZIL HCL 5 MG TABLET.
Who manufactures DONEPEZIL HCL 5 MG TABLET?
DONEPEZIL HCL 5 MG TABLET (NDC 31722073790) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.